
Boston Scientific Corporation – NYSE:BSX-PA
Boston Scientific stock price today
Boston Scientific stock price monthly change
Boston Scientific stock price quarterly change
Boston Scientific stock price yearly change
Boston Scientific key metrics
Market Cap | 175.44B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 1.2 |
Revenue | 14.70B |
EBITDA | 3.61B |
Income | 1.77B |
Revenue Q/Q | 13.77% |
Revenue Y/Y | 12.74% |
Profit margin | 5.5% |
Oper. margin | 16.03% |
Gross margin | 68.44% |
EBIT margin | 16.03% |
EBITDA margin | 24.59% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBoston Scientific stock price history
Boston Scientific stock forecast
Boston Scientific financial statements
Jun 2023 | 3.59B | 270M | 7.5% |
---|---|---|---|
Sep 2023 | 3.52B | 504M | 14.29% |
Dec 2023 | 3.72B | 505M | 13.56% |
Mar 2024 | 3.85B | 492M | 12.76% |
2019-10-23 | 0.38 | 0.39 |
---|---|---|
2020-02-05 | 0.44 | 0.46 |
2020-04-29 | 0.31 | 0.28 |
2020-07-29 | -0.02 | 0.08 |
Payout ratio | 0% |
---|
2019 | |
---|---|
2020 | 0.06% |
2021 | 0.09% |
2022 | 0.08% |
2023 | 0.03% |
Jun 2023 | 33601000000 | 15.11B | 44.99% |
---|---|---|---|
Sep 2023 | 34043000000 | 14.91B | 43.81% |
Dec 2023 | 35136000000 | 15.60B | 44.42% |
Mar 2024 | 36669000000 | 16.50B | 45% |
Jun 2023 | 658M | -840M | 43M |
---|---|---|---|
Sep 2023 | 698M | -197M | 16M |
Dec 2023 | 957M | -1.05B | 15M |
Mar 2024 | 164M | -285M | 1.56B |
Boston Scientific alternative data
Aug 2023 | 45,000 |
---|---|
Sep 2023 | 45,000 |
Oct 2023 | 45,000 |
Nov 2023 | 45,000 |
Dec 2023 | 45,000 |
Jan 2024 | 45,000 |
Feb 2024 | 45,000 |
Mar 2024 | 45,000 |
Apr 2024 | 45,000 |
May 2024 | 45,000 |
Jun 2024 | 45,000 |
Jul 2024 | 45,000 |
Boston Scientific other data
Period | Buy | Sel |
---|---|---|
Apr 2022 | 0 | 28134 |
May 2022 | 0 | 7500 |
Jun 2022 | 0 | 7500 |
Jul 2022 | 0 | 7500 |
Aug 2022 | 0 | 170092 |
Sep 2022 | 0 | 133328 |
Oct 2022 | 0 | 139149 |
Nov 2022 | 0 | 160653 |
Dec 2022 | 0 | 138876 |
Jan 2023 | 0 | 6751 |
Feb 2023 | 0 | 43695 |
Mar 2023 | 0 | 128984 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | BUTCHER ARTHUR C officer: EVP& Grp Pres, MedSurg.. | Common Stock | 6,703 | $47.97 | $321,543 | ||
Option | CARRUTHERS WENDY officer: EVP, Hum.. | Stock Option (Right to Buy) | 2,960 | $13.08 | $38,717 | ||
Option | CARRUTHERS WENDY officer: EVP, Hum.. | Stock Option (Right to Buy) | 3,448 | $16.31 | $56,237 | ||
Sale | CARRUTHERS WENDY officer: EVP, Hum.. | Common Stock | 11,671 | $47.6 | $555,575 | ||
Option | CARRUTHERS WENDY officer: EVP, Hum.. | Common Stock | 2,960 | $13.08 | $38,717 | ||
Option | CARRUTHERS WENDY officer: EVP, Hum.. | Common Stock | 3,448 | $16.31 | $56,237 | ||
Sale | BRENNAN DANIEL J. officer: EVP and .. | Common Stock | 30,000 | $46.66 | $1,399,920 | ||
Sale | BRENNAN DANIEL J. officer: EVP and .. | Common Stock | 30,000 | $46.66 | $1,399,920 | ||
Option | MONSON JONATHAN officer: SVP, Global Controller.. | Stock Option (Right to Buy) | 5,000 | $12.89 | $64,450 | ||
Sale | MONSON JONATHAN officer: SVP, Global Controller.. | Common Stock | 5,000 | $46.66 | $233,315 |
-
What's the price of Boston Scientific stock today?
One share of Boston Scientific stock can currently be purchased for approximately $116.59.
-
When is Boston Scientific's next earnings date?
Unfortunately, Boston Scientific's (BSX-PA) next earnings date is currently unknown.
-
Does Boston Scientific pay dividends?
No, Boston Scientific does not pay dividends.
-
How much money does Boston Scientific make?
Boston Scientific has a market capitalization of 175.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.29% to 14.24B US dollars. Boston Scientific earned 1.59B US dollars in net income (profit) last year or $0.08 on an earnings per share basis.
-
What is Boston Scientific's stock symbol?
Boston Scientific Corporation is traded on the NYSE under the ticker symbol "BSX-PA".
-
What is Boston Scientific's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Boston Scientific?
Shares of Boston Scientific can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Boston Scientific have?
As Jul 2024, Boston Scientific employs 45,000 workers.
-
When Boston Scientific went public?
Boston Scientific Corporation is publicly traded company for more then 5 years since IPO on 22 May 2020.
-
What is Boston Scientific's official website?
The official website for Boston Scientific is bostonscientific.com.
-
Where are Boston Scientific's headquarters?
Boston Scientific is headquartered at 300 Boston Scientific Way, Marlborough, MA.
-
How can i contact Boston Scientific?
Boston Scientific's mailing address is 300 Boston Scientific Way, Marlborough, MA and company can be reached via phone at +508 6834000.
Boston Scientific company profile:

Boston Scientific Corporation
bostonscientific.comNYSE
45,000
Medical - Devices
Healthcare
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Marlborough, MA 01752-1234
CIK: 0000885725
ISIN: US1011372067
CUSIP: 101137206